ITD-1 25 mg | 99.89%
TargetMol
ITD-1
Search Results
ITD-1 100 mg | 99.89%
TargetMol
ITD-1
SGX-523 25 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
Sacubitril/Valsartan 2 mg | 99.94%
TargetMol
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.
More Information Supplier PageSacubitril/Valsartan
GSK-LSD1 dihydrochloride 2 mg | Purity Not Available
TargetMol
GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
More Information Supplier PageGSK-LSD1 dihydrochloride
Isavuconazole 200 mg | 98.00%
TargetMol
Isavuconazole(BAL-4815; RO-0094815) is the active component of the new azole antifungal agent BAL8557 with MIC(50)s/MIC(90)s ranged from 0.002/0.004 mg/liter for C. albicans to 0.25/0.5 mg/liter for C. glabrata.
More Information Supplier PageIsavuconazole
ML204 200 mg | 99.98%
TargetMol
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier PageML204
ML204 25 mg | 99.98%
TargetMol
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier PageML204
ML204 2 mg | 99.98%
TargetMol
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier PageML204
PIK-294 100 mg | 99.00%
TargetMol
PIK-294
